OLD BLOG, NO LONGER IN USE! BIOC6006, Literature review topics - 2008

This will only be used once during the semester - when you are selecting your literature review topics. Look here to see if a paper has already been selected by a classmate. If it has, please choose a different one.

11.9.07

Smad3 is acetylated by p300/CBP to regulate its transactivation activity

Original Article

Oncogene (2007) 26, 500–508. doi:10.1038/sj.onc.1209826; published online 24 July 2006

Y Inoue1,4, Y Itoh1, K Abe1,5, T Okamoto2, H Daitoku3, A Fukamizu3, K Onozaki1 and H Hayashi1

These following are main information about this article:

As a signal of transforming growth factor-beta (TGF-beta), Smad proteins activate the trascription of target genes. This article shows that Smad3 is a direct target of the transcriptional co-activators p300/CBP, and the acetylation of Smad3, induced by p300/CBP occurs in the MH2 domain, is stimulated by TGF-beta. Base on this, the authors also propose a mechanism for the regulation of Smad3 by TGF-beta. Lys residue 378 in the MH2 domain (Smad3C) is a major acetylation site of Smad3 by p300/CBP. A reduction of the transcriptional activity of GAL4-Smad3C was observed by replacing Lys-378 with Arg; and the report also shows that acetylation of Smad3 by p300/CBP regulates the transcriptional activity of Smad3 by the observation of the potential transcriptional activity of GAL4-Smad3C, but not of the acetylation-resistant GAL4-Smad3C(K378R) mutant. Particularly, the authors direct their further study being required β€œto define the effect of acetylation on the intrinsic activity of Smad3 and biological activity of TGF-beta”.

Dang Minh Tam

ID: 41329142

11/09/2007